Methylene Chloride

Methylene Chloride

SCHEMBL318992

ClCCl.[Pd]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 460 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119331000-A Keli boron Synthesis method of roxburgh 圣嘉(滨海)生物医药科技有限公司 2025-01-21 CN claimed
CN-109705055-A Benzothiazole compound, preparation method thereof and application of benzothiazole compound as hypobromous acid probe 湖南城市学院 2019-05-03 CN claimed
US-10016752-B1 Method of making palladium nanoparticles KING SAUD UNIVERSITY (SA) 2018-07-10 US claimed
CN-105377871-B Preparation method of abiraterone and intermediate thereof 台湾神隆股份有限公司 2017-06-06 CN claimed
CN-105732550-A Preparing method of chiral 3-methylene-2,3-dihydro-furan compound 中国科学院大连化学物理研究所 2016-07-06 CN claimed
EP-1768988-B1 NOVEL PHENYL-BORONIC ACID DERIVATIVES AND METHODS FOR THE PREPARATION THEREOF GALDERMA RES & DEV (FR) 2009-01-28 EP claimed
EP-1768988-A1 NOVEL PHENYL-BORONIC ACID DERIVATIVES AND METHODS FOR THE PREPARATION THEREOF Galderma Research & Development, S.N.C. (FR) 2007-04-04 EP claimed
WO-2005061520-A1 NOVEL PHENYL-BORONIC ACID DERIVATIVES AND METHODS FOR THE PREPARATION THEREOF GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2005-07-07 WO claimed
CN-1286251-A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system PFIZER PROD INC (US) 2001-03-07 CN claimed
US-12624033-B2 KRAS inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2026-05-12 US disclosed
US-20260116903-A1 AROMATIC HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF RECURSION PHARMACEUTICALS INC (US) 2026-04-30 US disclosed
EP-4727939-A1 5-(CINNOLIN-6-YL)THIAZOLE COMPOUNDS FOR TREATING NEUROLOGICAL DISORDERS Prothena Biosciences Limited (IE) 2026-04-22 EP disclosed
EP-4727938-A1 BICYCLIC HETEROAROMATIC COMPOUNDS FOR TREATING NEUROLOGICAL DISORDERS Prothena Biosciences Limited (IE) 2026-04-22 EP disclosed
EP-4370517-B1 SYNTHESIS OF CHIRAL SUBSTITUTED PYRAZOLOPYRIMIDINE COMPOUNDS Galderma Holding SA (CH) 2025-12-24 EP disclosed
CN-1440403-A Quinazoline ditosylate compounds GLAXO GROUP LTD (GB) 2003-09-03 CN disclosed
CN-1378527-A Biaryl ether derivatives useful as monoamine reuptake inhibitors PFIZER PROD INC (US) 2002-11-06 CN disclosed
CN-1068325-C phenyl oxazolidinone antibacterial agents PHARMACIA & UPJOHN CO LLC (US) 2001-07-11 CN disclosed
CN-1290265-A Thrombin receptor antagonists SCHERING CORP (US) 2001-04-04 CN disclosed
CN-1286251-A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system PFIZER PROD INC (US) 2001-03-07 CN disclosed
CN-1162312-A Phenyloxazolidinone antimicrobials PHARMACIA & UPJOHN CO LLC (US) 1997-10-15 CN disclosed